International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: 10.5281/zenodo.12799834
Original Research Article
The Role of Hyperbilirubinemia as a Predictor of Gangrenous or Perforated Appendicitis
Published
Nov. 7, 2024
Abstract

Background: Acute appendicitis is a common surgical emergency, and diagnosing complicated cases such as gangrenous or perforated appendicitis remains challenging. Hyperbilirubinemia has been proposed as a potential diagnostic marker to aid in identifying these severe cases. Aim: To evaluate the role of hyperbilirubinemia in predicting gangrenous or perforated appendicitis and assess its diagnostic accuracy. Methods: A prospective observational study was conducted at Chamarajanagara Institute of Medical Sciences, Karnataka, from September 2022 to September 2023. One hundred patients with acute appendicitis who underwent emergency appendectomy were included. Serum bilirubin (total and direct) levels were measured, and intraoperative findings were confirmed via histopathology. Statistical analysis was performed to determine the sensitivity, specificity, and predictive values of hyperbilirubinemia. Results: Mean total bilirubin levels were significantly higher in patients with complicated appendicitis (2.4 ± 0.9 mg/dL) compared to those with uncomplicated appendicitis (0.8 ± 0.3 mg/dL, p < 0.001). Direct bilirubin levels were also elevated (0.8 ± 0.4 mg/dL vs. 0.2 ± 0.1 mg/dL, p < 0.001). Hyperbilirubinemia showed a sensitivity of 88%, specificity of 65%, positive predictive value of 60%, and negative predictive value of 90% in predicting complicated appendicitis. Conclusion:Hyperbilirubinemia is a useful adjunctive marker for predicting complicated appendicitis, showing high sensitivity and a strong negative predictive value. Its integration into diagnostic protocols may aid in the timely identification and treatment of high-risk cases.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
1712 Views
21 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved